News
AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...
The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S.
AstraZeneca may face a fine of up to $8 million in China over suspected unpaid taxes related to the import of its breast ...
The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...
The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...
AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...
A new commercial for AstraZeneca’s Truqap constructs a vision of the extra time that the AKT inhibitor can unlock for some ...
The screen program is part of the World Economic Forum's EDISON alliance 1 billion lives challenge and through the test, the ...
AstraZeneca partnered with Qure.ai to leverage its technology for assessing chest X-rays and determining potential lung ...
AstraZeneca posts Q1 revenue of $13.59 billion and a strong EPADS beat; oncology leads growth as China's tax probe and halts ...
The Anglo-Swedish pharmaceutical group on Tuesday reported revenue of $13.6bn in the first three months of the year, up 10 ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results